Once a formidable contender against giants like L’Oréal and Estée Lauder, Shiseido now faces its toughest battle in decades, struggling to recover from a costly misstep in North America and losing ground to nimble Asian competitors. But here’s where it gets controversial: could this iconic Japanese beauty brand’s downfall be a cautionary tale of failing to adapt to the lightning-fast changes in the global cosmetics market? Let’s dive in.
Six years ago, Shiseido made a bold move, investing $845 million to acquire Drunk Elephant, an American skincare brand aimed at capturing younger, social media-savvy consumers. Fast forward to today, and the company has written off more than half of that investment due to plummeting profits and sales. This isn’t just a financial setback—it’s a stark reminder of how quickly beauty trends evolve, with Korean and Chinese brands like Amorepacific and Kolmar Korea outpacing traditional players. These Asian competitors now dominate U.S. exports, leaving Shiseido scrambling to catch up.
The pandemic only exacerbated Shiseido’s woes, forcing the 154-year-old company to rethink its strategy. Its turnaround plan includes aggressive cost-cutting and a renewed focus on luxury brands like Clé de Peau Beauté. However, investors remain skeptical, with Shiseido’s stock hovering at just a third of its 2019 peak value. And this is the part most people miss: the company’s struggles aren’t just about one bad acquisition—they reflect deeper challenges, from high fixed costs to a lack of agility, issues that plague many long-standing Japanese corporations.
Drunk Elephant, once seen as a ticket to Instagram fame, quickly soured due to supply chain disruptions, misguided marketing targeting teens, and competition from affordable, ingredient-focused brands. Revenue for the brand shrank by a staggering 49% in the nine months ending September 2023. Is Shiseido’s focus on luxury enough to save it, or is it too little, too late?
Adding to the pressure, Shiseido’s reliance on the Chinese market has backfired, as post-pandemic demand slows and geopolitical tensions rise. Meanwhile, Chinese beauty brands are gaining popularity, further dimming the outlook for Japanese companies. With activist investors circling—like Oasis Management’s push for Kao to shed underperforming brands—Shiseido could be next if its turnaround falters. Independent Franchise Partners LLP, now its second-largest shareholder, is already watching closely.
CEO Kentaro Fujiwara’s plan to grow sales by 2-5% annually through 2030 sounds ambitious, but will it be enough? The company aims to streamline operations, strengthen luxury brands, and expand into medical and dermal cosmetics. Yet, analysts like Goldman Sachs’ Takashi Miyazaki argue that Shiseido’s best bet might be to narrow its focus rather than expand.
Here’s the burning question: Can Shiseido reclaim its former glory, or is it a relic of a bygone era in beauty? Let us know your thoughts in the comments—do you think Shiseido can bounce back, or is the cosmetics landscape too crowded for a comeback? One thing’s for sure: the beauty industry waits for no one, and Shiseido’s next moves will be under the microscope.
